VKTX Viking Therapeutics, Inc.


$ 35.10 $ 2.07 (6.26 %)    

Wednesday, 15-Oct-2025 19:52:45 EDT
QQQ $ 602.61 $ 4.22 (0.71 %)
DIA $ 463.04 $ 0.00 (0 %)
SPY $ 665.11 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.41 $ 6.60 (1.73 %)
$ na
$ 33.80
$ 34.75 x 1
$ 35.15 x 100
$ 33.62 - $ 35.66
$ 18.92 - $ 81.73
5,327,712
na
3.95B
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-viking-therapeutics-maintains-102-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ: VKTX) with a Buy and maintains $102...

 btig-reiterates-buy-on-viking-therapeutics-maintains-125-price-target

BTIG analyst Justin Zelin reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $125 price target.

Core News & Articles

https://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingre...

 jim-cramer-expects-palantir-to-reach-new-all-time-high

Market analysts and financial commentators provide crucial guidance in the volatile investment landscape. Cramer says no to VKT...

 benzinga-bulls-and-bears-sunrun-newegg-walmart--and-powell-offers-rate-cut-hope

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...

 vikings-42-plunge-splits-expertsa-129-strong-buy-or-clearly-inferior-drug

Viking (VKTX) stock plunged 42% after its obesity pill trial. Experts are split: some call it a $129 Strong Buy, others say it&...

 palantir-amd-oracle-viking-and-nvidia-why-these-5-stocks-are-on-investors-radars-today

U.S. stock indices closed mixed on Tuesday, with the Dow Jones Industrial Average edging up 0.02% to 44,922.27.

 viking-obesity-pill-faces-steep-climb-against-lillys-tirzepatide-analyst-calls-downtrend-reaction-extreme

Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock's sell-of...

 tech-stocks-drop-palantir-plunges-over-8-whats-moving-markets-tuesday

Tech stocks pulled back on Tuesday as the absence of fresh bullish catalysts prompted investors to take profits after the recen...

 hc-wainwright--co-reiterates-buy-on-viking-therapeutics-maintains-102-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $102 ...

 like-eli-lilly-viking-therapeutics-oral-weight-loss-drug-disappoints-stock-tanks

Viking Therapeutics reported positive Phase 2 results for VK2735, showing significant weight loss and safety in obesity patient...

Core News & Articles

INTCNVDAGOOGLVKTXUNHPLTRBULLRBLXCRWVAMDData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment 

 stock-market-today-sp-500-nasdaq-100-slip-but-dow-futures-riseintel-palo-alto-home-depot-in-focus-updated

U.S. stock futures were fluctuating on Tuesday following mostly unchanged moves from Monday. Futures of major benchmark indices...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION